Loading insider details...
Latest Form 4 (Jul 2, 2026): Grant/Award of 32,000 FULC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 32,000 | n/a |
| Jun 10, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 19,475 | n/a |
| May 1, 2026 | Avalyn Pharma Inc. (AVLN) | Grant/Award | 26,978 | n/a |
| Jun 30, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 36,000 | n/a |
| Jun 10, 2025 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 23,746 | n/a |
| Sep 16, 2024 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 23,746 | n/a |
| Jun 18, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |
| Mar 11, 2024 | Blueprint Medicines Corp (BPMC) | Sale | 12,464 | $1.13M |
| Mar 6, 2024 | Blueprint Medicines Corp (BPMC) | Grant/Award | 40,000 | n/a |
| Jun 29, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |